525 related articles for article (PubMed ID: 28263914)
1. The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS).
Tsume Y; Matsui K; Searls AL; Takeuchi S; Amidon GE; Sun D; Amidon GL
Eur J Pharm Sci; 2017 May; 102():126-139. PubMed ID: 28263914
[TBL] [Abstract][Full Text] [Related]
2. The Combination of GIS and Biphasic to Better Predict In Vivo Dissolution of BCS Class IIb Drugs, Ketoconazole and Raloxifene.
Tsume Y; Igawa N; Drelich AJ; Amidon GE; Amidon GL
J Pharm Sci; 2018 Jan; 107(1):307-316. PubMed ID: 28919384
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Dissolution of Fluconazole and Dipyridamole in Gastrointestinal Simulator (GIS), Predicting in Vivo Dissolution and Drug-Drug Interaction Caused by Acid-Reducing Agents.
Matsui K; Tsume Y; Amidon GE; Amidon GL
Mol Pharm; 2015 Jul; 12(7):2418-28. PubMed ID: 25985298
[TBL] [Abstract][Full Text] [Related]
4. The Introduction of a New Flexible In Vivo Predictive Dissolution Apparatus, GIS-Alpha (GIS-α), to Study Dissolution Profiles of BCS Class IIb Drugs, Dipyridamole and Ketoconazole.
Tsume Y; Patel S; Wang M; Hermans A; Kesisoglou F
J Pharm Sci; 2020 Nov; 109(11):3471-3479. PubMed ID: 32888960
[TBL] [Abstract][Full Text] [Related]
5. Utilization of Gastrointestinal Simulator, an in Vivo Predictive Dissolution Methodology, Coupled with Computational Approach To Forecast Oral Absorption of Dipyridamole.
Matsui K; Tsume Y; Takeuchi S; Searls A; Amidon GL
Mol Pharm; 2017 Apr; 14(4):1181-1189. PubMed ID: 28231003
[TBL] [Abstract][Full Text] [Related]
6. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
7. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs.
Higashino H; Hasegawa T; Yamamoto M; Matsui R; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
Mol Pharm; 2014 Mar; 11(3):746-54. PubMed ID: 24460473
[TBL] [Abstract][Full Text] [Related]
8. Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs.
Patel S; Zhu W; Xia B; Sharma N; Hermans A; Ehrick JD; Kesisoglou F; Pennington J
J Pharm Sci; 2019 Jan; 108(1):574-583. PubMed ID: 30395833
[TBL] [Abstract][Full Text] [Related]
9. A differential equation based modelling approach to predict supersaturation and in vivo absorption from in vitro dissolution-absorption system (idas2) data.
Li J; Spivey N; Silchenko S; Gonzalez-Alvarez I; Bermejo M; Hidalgo IJ
Eur J Pharm Biopharm; 2021 Aug; 165():1-12. PubMed ID: 33971275
[TBL] [Abstract][Full Text] [Related]
10. Revisiting Supersaturation of a Biopharmaceutical Classification System IIB Drug: Evaluation via a Multi-Cup Dissolution Approach and Molecular Dynamic Simulation.
Gan Y; Xu Y; Zhang X; Hu H; Xiao W; Yu Z; Sun T; Zhang J; Wen C; Zheng S
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836805
[TBL] [Abstract][Full Text] [Related]
11. Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum.
Mitra A; Fadda HM
Mol Pharm; 2014 Aug; 11(8):2835-44. PubMed ID: 25025699
[TBL] [Abstract][Full Text] [Related]
12. In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole.
Hens B; Pathak SM; Mitra A; Patel N; Liu B; Patel S; Jamei M; Brouwers J; Augustijns P; Turner DB
Mol Pharm; 2017 Dec; 14(12):4321-4333. PubMed ID: 28817288
[TBL] [Abstract][Full Text] [Related]
13. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.
Pathak SM; Ruff A; Kostewicz ES; Patel N; Turner DB; Jamei M
Mol Pharm; 2017 Dec; 14(12):4305-4320. PubMed ID: 28771009
[TBL] [Abstract][Full Text] [Related]
14. The effects of degree and duration of supersaturation on in vivo absorption profiles for highly permeable drugs, dipyridamole and ketoconazole.
Higashino H; Minami K; Takagi T; Kataoka M; Yamashita S
Eur J Pharm Biopharm; 2023 Aug; 189():48-55. PubMed ID: 37301301
[TBL] [Abstract][Full Text] [Related]
15. Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis.
Salehi N; Kuminek G; Al-Gousous J; Sperry DC; Greenwood DE; Waltz NM; Amidon GL; Ziff RM; Amidon GE
Mol Pharm; 2021 Sep; 18(9):3326-3341. PubMed ID: 34428047
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modelling.
Ruff A; Fiolka T; Kostewicz ES
Eur J Pharm Sci; 2017 Mar; 100():42-55. PubMed ID: 28011125
[TBL] [Abstract][Full Text] [Related]
17. The Evaluation of In Vitro Drug Dissolution of Commercially Available Oral Dosage Forms for Itraconazole in Gastrointestinal Simulator With Biorelevant Media.
Matsui K; Tsume Y; Amidon GE; Amidon GL
J Pharm Sci; 2016 Sep; 105(9):2804-2814. PubMed ID: 27020985
[TBL] [Abstract][Full Text] [Related]
18. Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test.
Heigoldt U; Sommer F; Daniels R; Wagner KG
Eur J Pharm Biopharm; 2010 Sep; 76(1):105-11. PubMed ID: 20472059
[TBL] [Abstract][Full Text] [Related]
19. Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults.
Psachoulias D; Vertzoni M; Goumas K; Kalioras V; Beato S; Butler J; Reppas C
Pharm Res; 2011 Dec; 28(12):3145-58. PubMed ID: 21674262
[TBL] [Abstract][Full Text] [Related]
20. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]